AlphaYou
Overview
Smart money at a glance
Filings to Oct 11, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 1 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 11- Open
- $3.75
- 52-wk high
- $8.48
- High
- $3.96
- 52-wk low
- $3.60
- Low
- $3.68
- Prev close
- $3.74
- Mkt cap
- $254.9M
- Volume
- 709.7K
- Beta
- 0.46
- P/S
- 563.6x
- P/B
- 1.5x
- Profit margin
- +0.0%
- Op margin
- +0.0%
- ROE
- -52.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about IMRX filings
Are insiders buying or selling Immuneering Corp (IMRX) stock?
Neither. Immuneering Corp (IMRX) insiders filed no open-market purchases or sales in the 90 days to Oct 11, 2026, according to SEC Form 4 filings.
Which members of Congress have traded IMRX recently?
None. No member of Congress disclosed a IMRX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this IMRX smart-money data?
This summary uses filings available on Oct 11, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net buying.
What funds are doing
Buys/Adds (1)
- BR
BlackRock
$13.9M
added
Sells/Trims (1)
- SS
State Street
$14.4M
trimmed
What insiders are doing
Buys (2)
- ZB
Zeskind Benjamin J.
$11K
bought
- HB
Hall Brett Matthew
$25K
bought
How top traders are positioned
No tracked top-trader positions in IMRX right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Results versus expectations
No earnings history.
Reports Nov 11, 2026, in 31 days
Financials
Is the business strong?
This company is running thin margins.
- Net margin
- 0.0%
- Market cap
- $255M
Valuation
- P/S563.62
- P/B1.49
Quality
- Operating margin0.0%
- ROE-52.1%
- ROA-32.8%
Growth
- Beta0.46
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace